Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical. Although the screening rates in the target pop […]
Computed tomographic colonography (CTC), also known as virtual colonoscopy, remains effective in screening older patients for colorectal cancer (CRC), produces low referral for colonoscopy rates similar to other screening exams now covered by Medicare, and does not result in unreasonable levels of additional testing resulting from extracolonic findings, as […]
Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, as per research from The University of Texas M. D. Anderson Cancer Center. The findings appear in the Dec. 2 issue of JAMA.......
Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how two cancer-promoting genes enhance a tumor's capacity to grow and survive under conditions where normal cells die. The knowledge, they say, may offer new therapys that starve cancer cells of a key nutrient - sugar. However, the researchers caution that research does not suggest […]
The Access to Medical Imaging Coalition (AMIC) announced recently that a study published in this month's Journal of Nuclear Medicine demonstrated the tremendous benefits of advanced imaging in the assessment of colorectal liver metastases. Dr. Theo Ruers lead a team of scientists in evaluating the benefits of F-fluorodeoxyglucose (FDG) positron emissio […]